Renal Failure,
Journal Year:
2025,
Volume and Issue:
47(1)
Published: May 6, 2025
Ferroptosis
is
a
regulated,
iron-dependent
form
of
cell
death
driven
by
lipid
peroxidation
and
distinct
from
apoptosis,
necroptosis,
pyroptosis.
Recent
studies
implicate
ferroptosis
as
central
contributor
to
the
pathogenesis
renal
fibrosis,
hallmark
chronic
kidney
disease
associated
with
high
morbidity
progression
end-stage
failure.
This
review
synthesizes
current
evidence
linking
ferroptotic
signaling
fibrotic
remodeling
in
kidney,
focusing
on
iron
metabolism
dysregulation,
glutathione
peroxidase
4
(GPX4)
inactivation,
peroxide
accumulation,
ferroptosis-regulatory
pathways
such
FSP1-CoQ10-NAD(P)H
GCH1-BH4.
We
detail
how
tubular
epithelial
cells
modulates
pro-fibrotic
cytokine
release,
macrophage
recruitment,
TGF-β1-driven
extracellular
matrix
deposition.
Moreover,
we
explore
therapeutic
vulnerability
highlighting
promising
agents
including
chelators,
GPX4
activators,
anti-lipid
peroxidants,
exosome-based
gene
delivery
systems.
By
consolidating
emerging
preclinical
data,
this
provides
comprehensive
mechanistic
framework
identifies
translational
opportunities
for
targeting
disease.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 28, 2025
Diabetic
nephropathy
(DN)
is
a
common
complication
of
diabetes
and
major
cause
end-stage
renal
disease,
with
complex
pathogenesis
involving
inflammation,
oxidative
stress,
fibrosis,
ferroptosis.
Ferroptosis
linked
to
DN
progression,
yet
treatment
options
are
limited,
particularly
for
targeting
Dapagliflozin
(DAPA),
an
SGLT2
inhibitor,
shows
protective
effects
in
diabetes,
but
its
role
fibrosis
ferroptosis
unclear.
This
study
investigated
DAPA's
effect
on
by
inhibiting
ferroptosis,
using
streptozotocin-induced
diabetic
mouse
model.
Results
indicated
that
DAPA
improved
function,
reduced
suppressed
markers
mice.
In
vitro,
inhibited
HK-2
cells
under
high
glucose
conditions.
Molecular
docking
network
pharmacology
suggested
anti-fibrotic
anti-ferroptotic
may
involve
the
Nrf2
TGF-β
signaling
pathways.
also
serum
creatinine
blood
urea
nitrogen
mice,
glomerulosclerosis
interstitial
decreased
iron
deposition,
enhanced
antioxidant
activity.
Overall,
multi-target
mechanisms
significantly
improve
suggesting
potential
as
targeted
therapy
against
Future
studies
should
further
explore
applications.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 12, 2025
Background
Renal
fibrosis
is
a
hallmark
and
the
final
outcome
of
chronic
kidney
disease
(CKD).
Jingtian
Granule
(JT),
traditional
formula
used
in
clinical
treatment
CKD
for
many
years.
However,
mechanism
action
JT
against
renal
interstitial
remain
unknown.
Objective
This
study
aimed
to
explore
potential
effects
mechanisms
on
adenine
-
diet
induced
mice.
Methods
was
mice
by
treated
with
JT.
function
assessed
measuring
blood
urea
nitrogen
serum
creatinine
levels.
Masson’s
staining
type
I
collagen
expression
were
evaluate
deposition.
RNA
sequencing
analyze
levels
mRNA
mouse
samples
after
treatment.
The
glutathione
(GSH)
malondialdehyde
(MDA)
measured
assess
lipid
peroxidation
kidneys.
Iron
metabolism
detected
Prussian
blue
measurement
iron
content.
protein
SIRT3,
P53,
peroxidase
4
(GPX4),
solute
carrier
family
7
member
11
(SLC7A11)
Western
blot.
Subsequently,
under
premise
SIRT3
knockout,
function,
level,
level
detected,
mitochondrial
damage
observed
transmission
electron
microscope
(TEM).
In
addition,
human
proximal
tubule
epithelial
cells
(HK
2)
Erastin
induce
ferroptosis,
followed
exposure
reactive
oxygen
species
(ROS)
detected.
Results
significantly
reduced
deposition
identified
20
mRNAs
that
differentially
expressed
response
Bioinformatics
analysis
revealed
key
regulated
activated
fibrotic
kidneys
inhibit
acetylation
P53.
Under
did
not
show
significant
therapeutic
inhibiting
ferroptosis
fibrosis.
vitro
experiments
also
showed
promoted
downregulation
ROS.
Conclusion
related
ability
modulate
SIRT3/P53
signaling
pathway
may
be
viable
approach
Journal of Medicinal Food,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 18, 2025
Renal
fibrosis
is
a
common
outcome
in
many
progressive
renal
diseases.
Unilateral
ureteral
obstruction
(UUO)
known
to
induce
oxidative
stress
and
inflammation
the
kidneys,
leading
development
of
fibrosis.
Fermented
strawberry
(Fragaria
x
ananassa
Duch.)
possesses
antioxidant
properties;
however,
its
effect
on
remains
unclear.
This
study
aimed
evaluate
impact
fermented
dry
powder
(FSP)
by
assessing
proinflammatory
cytokines,
markers,
underlying
mechanisms.
Male
Sprague-Dawley
rats
were
subjected
UUO
surgery
tubulointerstitial
obstructive
nephropathy.
Ten
days
postsurgery,
randomly
divided
into
four
groups
(n
=
6),
including
sham-operated
control
group.
FSP
was
administered
orally
at
doses
0.05
or
0.5
g
kg-1
body
weight
daily
for
21
days.
treatment
significantly
improved
function,
reduced
tubular
dilation,
decreased
interstitial
volume
rats.
levels
tumor
necrosis
factor-α
interleukin-6,
while
enhancing
activities
enzymes
such
as
superoxide
dismutase
catalase.
Treatment
with
resulted
reduction
collagen
deposition
kidneys
49%
69%,
respectively,
compared
increased
E-cadherin
expression
α-smooth
muscle
actin
level
Furthermore,
transforming
growth
factor-β
Smad2/3
upregulating
Smad7
expression.
These
findings
suggest
that
mitigates
fibrosis,
likely
through
modulation
Smad
signaling
attenuation
inflammation.
Renal Failure,
Journal Year:
2025,
Volume and Issue:
47(1)
Published: May 6, 2025
Ferroptosis
is
a
regulated,
iron-dependent
form
of
cell
death
driven
by
lipid
peroxidation
and
distinct
from
apoptosis,
necroptosis,
pyroptosis.
Recent
studies
implicate
ferroptosis
as
central
contributor
to
the
pathogenesis
renal
fibrosis,
hallmark
chronic
kidney
disease
associated
with
high
morbidity
progression
end-stage
failure.
This
review
synthesizes
current
evidence
linking
ferroptotic
signaling
fibrotic
remodeling
in
kidney,
focusing
on
iron
metabolism
dysregulation,
glutathione
peroxidase
4
(GPX4)
inactivation,
peroxide
accumulation,
ferroptosis-regulatory
pathways
such
FSP1-CoQ10-NAD(P)H
GCH1-BH4.
We
detail
how
tubular
epithelial
cells
modulates
pro-fibrotic
cytokine
release,
macrophage
recruitment,
TGF-β1-driven
extracellular
matrix
deposition.
Moreover,
we
explore
therapeutic
vulnerability
highlighting
promising
agents
including
chelators,
GPX4
activators,
anti-lipid
peroxidants,
exosome-based
gene
delivery
systems.
By
consolidating
emerging
preclinical
data,
this
provides
comprehensive
mechanistic
framework
identifies
translational
opportunities
for
targeting
disease.